AI model for
accelerating translational medicine
and drug discovery
accelerating translational medicine
and drug discovery
AI model for
accelerating translational medicine
and drug discovery
accelerating translational medicine
and drug discovery
Previous slide
Next slide
PARTNERING - COLLABORATION MAKES US BETTER!
AgnistaBio enables its partners to swiftly
(1) discover highly developable native antibody against
challenging target protein and determine its epitope/paratope;
(2) identify interacting proteins/enzymes against the target protein and its detail 3D structure
for accelerating drug design on a proteome scale in short lead time.
Drug Development
AgnistaAI accelerates the discovery of novel therapeutic antibodies
and uncovers its unexpected interacting proteins to avoid potential side effects in clinics.